In vitro functional experiments indicated that ANXA5 was involved in the regulation of HCC cells proliferation, migration, and invasion, and knockdown of its expression could inhibit the malignant phenotype of HCC (Fig. S8), and similar results were also observed after CFL1 knockdown treatment (Fig. S9). Here, ANXA5 is linked to hepatocellular carcinoma.